SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-QSB/A
[X] Quarterly report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
For the quarterly period ended
June 30, 1996
Commission file number: 0-18933
Rochester Medical Corporation
(EXACT NAME OF SMALL BUSINESS ISSUER AS SPECIFIED IN ITS CHARTER)
Minnesota 41-1613227
(STATE OR OTHER JURISDICTION OF (IRS EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
1500 Second Avenue N. W., Stewartville, MN 55976
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
(507) 533-4203
ISSUER'S TELEPHONE NUMBER
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes _X_ No ___
Indicate the number of shares outstanding of each of the issuer's classes of
common stock as of the latest practicable date:
4,127,500 Common Shares as of August 2, 1996.
This form 10QSB/A is being submitted to include exhibit 27, the Financial
Data Schedule.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits:
Exhibit 27. Financial Data Schedule
(b) Reports on Form 8-K:
None
SIGNATURES
In accordance with the requirements of the Exchange Act, the
registrant has caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
Rochester Medical Corporation
Date: October 16, 1996 By: /s/ Anthony J. Conway
---------------------
Anthony J. Conway
Chief Executive Officer,
Date: October 16, 1996 By: /s/ Brian J. Wierzbinski
------------------------
Brian J. Wierzbinski
Chief Financial Officer
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-1996
<PERIOD-END> JUN-30-1996
<CASH> 11,110,094
<SECURITIES> 6,913,483
<RECEIVABLES> 1,373,613
<ALLOWANCES> 34,250
<INVENTORY> 1,093,833
<CURRENT-ASSETS> 20,550,158
<PP&E> 3,414,019
<DEPRECIATION> 1,387,466
<TOTAL-ASSETS> 22,980,502
<CURRENT-LIABILITIES> 732,436
<BONDS> 0
0
0
<COMMON> 23,946,911
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 22,980,502
<SALES> 3,753,254
<TOTAL-REVENUES> 3,753,254
<CGS> 2,599,363
<TOTAL-COSTS> 2,420,129
<OTHER-EXPENSES> 0
<LOSS-PROVISION> (1,266,238)
<INTEREST-EXPENSE> (213,916)
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (890,530)
<EPS-PRIMARY> (0.24)
<EPS-DILUTED> (0.24)
</TABLE>
